With cigarette sales growth falling in almost every country in the world, the persistently high valuations of tobacco stocks don't make a lot of sense, says Ranger International.
In a note to investors titled Tobacco stocks as melting ice cubes, US fund manager Ranger International said it was “stunned” by the “rapid decay in [tobacco] industry fundamentals (social responsibility aside)”.
The “steep” valuations of tobacco companies were seemingly at odds with the “basic story of falling demand for tobacco products”, the note said.
Year-on-year cigarette sales volume was negative in almost every country measured by Philip Morris and Reynolds America. Turkey, Ukraine, France and Mexico were the exceptions and growth was flat in Indonesia.
“We like to call large companies with falling organic growth ‘melting ice cubes’,” Ranger International said.
“They may be large and many even dominate their industry, but the business environment has changed such that organic growth continues to slide year after year.”
“The challenges faced by [heavily disrupted companies like Eastman Kodak] are well known, yet tobacco companies have persuaded investors that their inevitable decay can be managed.”
Despite being melting ice cubes, tobacco stocks are ‘hot’, Ranger International said.
“Tobacco companies have already borrowed heavily to buy back shares and shrink the annual dividend outlay. How likely is a repeat performance, over say, the next five years?” the fund manager asked.
“In our view, the global trend toward less smoking will only gain momentum. Health organisations and governments are imposing limits on smoking.
“The multi-decade growth story in this industry has turned to one of decay. This dynamic includes emerging markets where growth is no longer strong and currencies have become a headwind.
“Leaving aside the socially responsible concerns of tobacco, why should tobacco stocks be selling at premiums when they historically trade at discounts?”
EXCLUSIVE: A new paper is set to be released by the Queensland Investment Corporation which provides an in-depth analysis on the US/China t...
A medicinal cannabis company has listed on the ASX after completing their funding via an IPO. ...
New research from InvestSMART has shone a light on the fund management industry, revealing billions in underperforming funds. ...